Podcast: “Clinical Evidence, The Key to Market Adoptions”

Market access strategies for medical devices

In the latest Global Medical Device podcast episode, Etienne Nichols is joined by Shaherah Yancy, CEO of Research Lifecycle Solutions. They dive deep into the critical importance of developing robust clinical and regulatory strategies for MedTech companies. Shaherah shares her extensive experience in the field, providing practical advice on securing funding, ensuring market access, and achieving market adoption. They also explore the nuances of clinical evidence, the significance of strategic planning, and the role of advisory panels in navigating the MedTech landscape. Listen to the full episode to gain valuable insights from one of the leading experts in the field. Don’t miss out on this opportunity to learn from Shaherah’s wealth of knowledge. Tune in: Clinical Evidence: The Key to Market Adoption (greenlight.guru)

Why is clinical evidence important?

  1. Strategic Planning is Essential: Early and comprehensive planning for clinical and regulatory strategies can significantly enhance a company’s chances of success.
  2. Clinical Evidence is Critical: Collecting robust clinical data is vital for both market access and long-term market adoption.
  3. Market Adoption Over Market Access: The ultimate goal should be market adoption, not just getting to market.

Memorable quotes from this episode

  • “Market access is a milestone. Market adoption is the goal.” – Shaherah Yancy
  • “Understanding the problem you’re solving is crucial for your strategy.” – Shaherah Yancy
  • “Don’t be afraid of clinical evidence; it’s your key to success.” – Shaherah Yancy

Key timestamps

  • 00:00 – 03:00 Introduction and Sponsor Message
  • 03:01 – 05:20 Introduction to Shaherah Yancy and her background
  • 05:21 – 10:30 Importance of Clinical and Regulatory Strategies
  • 10:31 – 17:15 Challenges of Securing Funding and Developing Strategy
  • 17:16 – 25:45 Differences Between Market Access and Market Adoption
  • 25:46 – 33:50 Developing Effective Clinical Plans for Market Adoption
  • 33:51 – 39:40 Importance of Evidence and Study Design
  • 39:41 – 48:00 Examples and Case Studies from Early Stage Companies
  • 48:01 – 55:15 Endpoints for Market Adoption
  • 55:16 – 01:02:30 Strategies for Novel Technologies
  • 01:02:31 – 01:07:45 Final Advice and Contact Information

 

RLS presents at BioTech Breakfast during New York Tech Week

BioTech Breakfast at NY Tech Week

Phase Capital and 615.vc hosted a dynamic BioTech Breakfast as part of New York TECH WEEK by a16z, bringing together brilliant minds and innovative thinkers in the biotech industry in one of the most vibrant cities of all, New York!
Biotech thrives on collaboration. The complexity and depth of knowledge required in this field make it essential to connect with peers who have complementary skills and insights.
This was one of the driving forces behind organizing this breakfast. In the room were venture studios, biotech founders, biomedical students, investors, and industry leaders, all eager to connect and share their expertise. The energy and enthusiasm were palpable as discussions included the latest advancements, challenges, and opportunities in biotech (and exchange of LinkedIn QR codes!)
A huge thank you to everyone who attended and contributed to the rich discussions. Thanks also to our amazing partners and sponsors: Lisa Voronkova of OVA Solutions, Shaherah Yancy of Research Lifecycle Solutions, and Nadian Zak of Zak Human Solutions.